A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
Clinical trial NCT03663946 · COMPLETED
Trial details
- NCT number
- NCT03663946
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-18
- Primary completion
- 2020-05-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.